Why Moderna Stock Crushed the Market Today
Yahoo! Finance
The coronavirus pandemic might, just might, be easing, but top COVID-19 vaccine maker Moderna (NASDAQ: MRNA) was ascendant on Tuesday. Shortly before market close on Monday, the Food and Drug Administration (FDA) announced it had authorized a set of Moderna's latest Spikevax COVID booster vaccine for use. Strictly speaking, that company isn't covered under Moderna's emergency use authorization (EUA) for the booster.
Continue Reading